Aimmune News Today

Analysis to be Presented Showed Peanut Allergy Treatment with PALFORZIA was Associated with Improvements in Health-Related Quality of Life among Patients and Caregivers -Additional Data to be Presented

Consumer News Jan 11, 2021 11:53 AM By Sabrina Emms A new enzyme treatment is being used to develop hypoallergenic peanuts. Photo courtesy of Shutterstock Harmless to some but anything but to others, a peanut allergy is a big deal. Around 2% of children have allergies to peanuts, which is one of eight recognized major food allergens.   In January 2020, pre-Covid, the FDA approved a drug to treat peanut allergies in children. Called Palforzia, it isn’t a traditional drug, but inst...